Grandaliano, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 2.226
NA - Nord America 2.082
EU - Europa 1.245
SA - Sud America 489
AF - Africa 68
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.127
Nazione #
US - Stati Uniti d'America 2.003
SG - Singapore 1.230
BR - Brasile 414
CN - Cina 356
SE - Svezia 281
IT - Italia 238
VN - Vietnam 206
FR - Francia 182
DE - Germania 153
IE - Irlanda 106
JP - Giappone 82
ID - Indonesia 77
GB - Regno Unito 70
IN - India 54
RU - Federazione Russa 48
FI - Finlandia 42
HK - Hong Kong 39
PL - Polonia 37
MX - Messico 32
CA - Canada 29
AR - Argentina 27
PK - Pakistan 26
TR - Turchia 20
BD - Bangladesh 19
IQ - Iraq 19
NL - Olanda 19
UA - Ucraina 19
ZA - Sudafrica 19
KR - Corea 18
AT - Austria 16
AU - Australia 12
SA - Arabia Saudita 12
VE - Venezuela 12
EC - Ecuador 11
KE - Kenya 11
UZ - Uzbekistan 10
OM - Oman 8
CI - Costa d'Avorio 7
CO - Colombia 7
IR - Iran 7
JO - Giordania 7
MA - Marocco 7
ES - Italia 6
UY - Uruguay 6
DZ - Algeria 5
AL - Albania 4
BY - Bielorussia 4
CL - Cile 4
CR - Costa Rica 4
LB - Libano 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BE - Belgio 2
BO - Bolivia 2
CY - Cipro 2
EU - Europa 2
HR - Croazia 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
PE - Perù 2
PH - Filippine 2
SO - Somalia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
BW - Botswana 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 6.123
Città #
Singapore 669
San Jose 283
Ashburn 254
Chandler 204
Dublin 103
Ho Chi Minh City 85
Beijing 76
Tokyo 76
Fairfield 75
Rome 75
Lauterbourg 72
Jakarta 68
Los Angeles 62
Dallas 56
New York 56
Hefei 55
Princeton 55
Hanoi 51
Wilmington 48
San Mateo 45
Frankfurt am Main 39
Moscow 38
Hong Kong 34
Warsaw 30
São Paulo 28
Nuremberg 27
The Dalles 27
Boston 25
Council Bluffs 25
Milan 24
Munich 24
Santa Clara 24
Lappeenranta 23
Bremen 20
Chicago 19
Kent 19
Seoul 18
Buffalo 17
Orem 17
Phoenix 15
Washington 15
Seattle 14
Belo Horizonte 13
Boardman 13
Helsinki 13
Woodbridge 13
Chennai 12
Hangzhou 12
Mexico City 12
Paris 12
Baghdad 11
Bari 11
Cambridge 11
Johannesburg 11
Amsterdam 10
Ankara 10
Denver 10
Nairobi 10
Redwood City 10
Rio de Janeiro 10
Campinas 9
London 9
Manchester 9
Montreal 9
Multan 9
Roubaix 9
Ann Arbor 8
Brooklyn 8
Düsseldorf 8
Elk Grove Village 8
Falkenstein 8
Hyderabad 8
Abidjan 7
Da Nang 7
Guangzhou 7
Houston 7
Marseille 7
Santo André 7
Tashkent 7
Toronto 7
Amman 6
Atlanta 6
Augusta 6
Brasília 6
Montevideo 6
Norwalk 6
St Louis 6
Stockholm 6
Tianjin 6
Vienna 6
Bexley 5
City of London 5
Curitiba 5
Guayaquil 5
Haiphong 5
Maceió 5
Mumbai 5
Nova Iguaçu 5
Portsmouth 5
Salvador 5
Totale 3.462
Nome #
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 183
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 158
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 151
Digital integration between hospitals and local health authorities for enhanced vaccination coverage among frail patients: the CareVax study protocol 138
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 131
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 128
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 120
Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease 115
COVID-19 and kidney transplantation: an Italian Survey and Consensus 115
The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation 105
SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis 101
Angiosarcoma of an Arteriovenous Fistula for Hemodialysis in a Kidney Transplant Recipient Affected by Lowe's Syndrome 101
Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists 96
Crystal-induced colitis 96
Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study 91
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 91
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 90
Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation? 88
Dialysis-related transcriptomic profiling: The pivotal role of heparanase 86
A type i interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 86
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 85
IgE-mediated immune response and antibody-mediated rejection 85
Coagulation and Fibrinolysis in Kidney Graft Rejection 85
Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial 85
Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options 84
Maladaptive Repair and Progression to CKD 83
Editorial: Kidney Transplantation and Innate Immunity 83
Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries 82
On-line hemodiafiltration modulates atherosclerosis signaling in peripheral lymphomonocytes of hemodialysis patients 82
Empagliflozin in Patients with Chronic Kidney Disease 80
Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target 80
mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction 80
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 80
Waves of infection and waves of communication: the importance of sharing in the era of Covid-19 79
Late Recurrence of C3 Glomerulopathy After SARS-CoV-2 Infection in a Long-Term Kidney Transplant Recipient: A Case Report 78
Acute Kidney Injury to Chronic Kidney Disease Transition 77
Nocturnal haemodialysis is associated with a reduced occurrence of low triiodothyronine serum levels in haemodialysed patients 77
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 76
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat 73
Nephrolithiasis in the elderly 73
LPS-binding protein modulates acute renal fibrosis by inducing pericyte-to-myofibroblast trans-differentiation through TLR-4 signaling 72
Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants 72
The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): A randomized, controlled trial 72
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 71
Emerging role of Lipopolysaccharide binding protein in sepsis-induced acute kidney injury 71
Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells 70
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 69
Assessment and management of heart failure in patients with chronic kidney disease 68
Pre-Transplant Expression of CCR-2 in Kidney Transplant Recipients Is Associated With the Development of Delayed Graft Function 68
MTOR and aging: An old fashioned dress 68
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 68
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population 68
Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia 66
Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study 65
Modulation of complement activation by pentraxin-3 in prostate cancer 65
Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells 64
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy 62
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 61
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 60
To discard or not to discard: Transplantation and the art of scoring 59
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 59
Aldosterone: From Essential Tubular Regulator to Pathological Driver—Physiology, Disease, and Therapeutic Advances 57
Complement modulation of anti-aging factor klotho in ischemia/reperfusion injury and delayed graft function 57
LPS removal reduces CD80-mediated albuminuria in critically ill patients with gram-negative sepsis 56
It is the time to rethink the criteria to define transplantable kidneys. Should we combine histological and clinical evaluation? 56
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 55
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection 55
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: A multicohort observational study 54
Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients 54
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 54
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 54
Increased Complement Gene Expression in Circulating B Cells From Kidney Transplant Recipients With Chronic Antibody-Mediated Rejection 52
Treatment with rituximab in idiopathic membranous nephropathy 52
Soluble Serum alpha Klotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 52
Serum Fetuin A in Hemodialysis: A Link Between Derangement of Calcium-Phosphorus Homeostasis and Progression of Atherosclerosis? 48
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury 47
Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula 46
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study 40
Diabetes Mellitus in Kidney Transplant Recipients and New Hypoglycemic Agent Options 35
Efficacy and Safety of Low-Dose ATG Plus Basiliximab Induction in Deceased Donor Kidney Transplantation 33
Timely AVF creation in late-referral hemodialysis patients, a two-cohort study: Too late to plan, not too late to act 11
Totale 6.243
Categoria #
all - tutte 30.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 13 35
2021/2022399 54 7 12 20 12 21 13 70 17 16 103 54
2022/2023716 99 111 66 87 56 97 22 57 93 3 19 6
2023/2024506 11 123 20 72 16 61 21 12 8 40 51 71
2024/20251.265 18 12 78 50 52 66 70 54 217 98 281 269
2025/20263.150 543 135 231 391 548 145 589 141 205 202 20 0
Totale 6.243